×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Ruff Shamim

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorJul 28, 2023Option Exercise$92.208,235759,26715,594Aug 01, 2023, 04:41 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorJul 28, 2023Sale$164.538,2351,354,8877,359Aug 01, 2023, 04:41 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorJun 07, 2023Option Exercise$93.612,136199,9517,359Jun 09, 2023, 04:32 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorMar 10, 2023Sale$83.735,740480,6105,223Mar 13, 2023, 05:23 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorMar 10, 2023Option Exercise$34.505,740198,04210,963Mar 13, 2023, 05:23 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorJun 08, 2022Option Exercise$34.765,105177,4505,223Jun 09, 2022, 04:47 PM
RETAREATA PHARMACEUTICALS INCRuff ShamimDirectorJan 03, 2022Option Exercise$27.321183,224118Jan 05, 2022, 04:04 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Chief Regulatory AffairsMay 22, 2018Option Exercise$89.221,305116,43231,936May 24, 2018, 06:06 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Chief Regulatory AffairsMar 15, 2018Option Exercise$23.932,50059,81329,465Mar 16, 2018, 06:13 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Chief Regulatory AffairsMar 15, 2018Option Exercise$81.2273659,77828,809Mar 16, 2018, 06:13 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualNov 06, 2017Option Exercise$14.7610,000147,60037,045Nov 08, 2017, 08:13 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualNov 06, 2017Sale$55.0010,000550,00027,045Nov 08, 2017, 08:13 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualOct 03, 2017Option Exercise$14.7611,500169,74038,545Oct 05, 2017, 07:24 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualOct 03, 2017Sale$50.0011,500575,00027,045Oct 05, 2017, 07:24 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualAug 03, 2017Option Exercise$37.882,882109,17027,045Aug 07, 2017, 04:44 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualJul 20, 2017Option Exercise$13.716,25085,68827,312Jul 21, 2017, 09:47 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualJul 20, 2017Sale$42.006,250262,50021,062Jul 21, 2017, 09:47 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualJul 21, 2017Option Exercise$14.125,88883,13325,450Jul 21, 2017, 09:47 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualJul 21, 2017Sale$44.005,888259,07221,062Jul 21, 2017, 09:47 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualMar 19, 2017Option Exercise$30.301775,36321,062Mar 21, 2017, 06:01 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualNov 08, 2016Option Exercise$26.241,00026,24021,239Nov 10, 2016, 08:20 AM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualSep 22, 2016Option Exercise$13.907,311101,62327,550Sep 30, 2016, 09:58 PM
SRPTSarepta Therapeutics, Inc.Ruff ShamimSVP, Regulatory Affairs & QualSep 22, 2016Sale$60.007,311438,66020,239Sep 30, 2016, 09:58 PM